T1	Chemical	36 46	crizotinib
T2	Disease	71 124	ALK rearranged non-small cell lung cancer ( NSCLC ) .
R1	treats	Arg1:T1	Arg2:T2
R2	influences	Arg1:T2	Arg2:T1
